Sermorelin is a biological active analog of growth hormone releasing hormone (GHRH) that's generated by the human brain to stimulate production and release of growth hormone by the pituitary gland. Benign prostate enlargement and prostate cancer are regarded as stimulated by testosterone. The possibility of increased risk of these conditions with testosterone supplementation is of great anxiety because treatments for both illnesses contain androgen suppression. Testosterone treatment has been associated with increased prostate volume, although not always above high -ordinary amounts.
Women with diminished sex drive have been shown to have lower free testosterone levels. In a 12-week trial 51 of 34 women, testosterone therapy (1% cream, 10 mg per day applied to the thigh) improved well being, mood, and sexual function in premenopausal women with low libido and low testosterone levels. Testosterone is used for women with Turner's syndrome, premature ovarian failure, HIV infection, or chronic corticosteroid use.
He also highlighted as testosterone treatment may not have an impact that given these study results, it's important for doctors to continue to vigorously handle recognized cardiovascular
disease risk factors in patients. These two studies come on the heels of a recent pooled analysis by researchers at Beth Israel Deaconess Medical Center in Boston, which cast further doubt on the link between testosterone therapy and cardiovascular risk and implied a positive association between higher testosterone levels and progress in decrease in cardiovascular risk. It really is a medical fact that girls and all men begin to age faster after they reach their forties.
In other words, the guys who used testosterone treatment had a 30 percent increased risk of heart attack, stroke or dying, compared with guys who did not use the hormone, and the results held after being fixed for several other factors that could have influenced the outcomes, according to the study, published today (Nov. Doctors and http://www.rand.org/news/press/2005/05/31.html
patients should be wary of the aggressive marketing used by testosterone makers, Cappola said. The researchers said the new study was prompted by a recent clinical trial of testosterone therapy in men who were at high risk for heart disease.